<DOC>
	<DOCNO>NCT02669043</DOCNO>
	<brief_summary>Anxious depression particularly difficult-to-treat subtype depression . Patients anxious depression respond well currently available antidepressant medication . Nevertheless , previous study , low dose IV ketamine , rapidly decrease symptom depression within hour many patient `` treatment-resistant '' depression , associate superior efficacy individual anxious compare non-anxious depression . In order understand unique effect fully , current protocol aim delineate biomarkers ketamine 's effect among individual treatment-resistant anxious depression compare nonanxious depression .</brief_summary>
	<brief_title>Physiological Cognitive Biomarkers Ketamine 's Antidepressant Effects</brief_title>
	<detailed_description />
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>1. 1864 year old , 2. read , understand , provide write informed consent English , 3. meet criterion primary psychiatric diagnosis Major Depressive Disorder ( MDD ) ≥ 4 week , 4. history ≥1 fail medication trial current depression , 5. stable adequate dose FDAapproved antidepressant medication ≥28 day , 6. maintain treat doctor agreement study participation , 7. reliable chaperone accompany home follow completion ketamine infusion day , 8. generally healthy , assessed medical history , physical examination ( include vital sign ) , clinical laboratory evaluation , electrocardiogram ( EKG ) , 9. nonchildbearing potential use acceptable form birth control ( female ) . 1. delirium dementia diagnosis , 2. unstable medical illness clinically significant laboratory result , 3. history clinically significant cardiovascular disease electrocardiogram ( EKG ) finding , medical condition put patient risk possible cardiac side effect ( e.g. , requirement cardiac pacemaker ) alter brain morphology ( e.g. , recent head trauma , post intracranial surgery , intracranial mass bleed unstable sleep apnea ) , blood pressure &gt; 140/95 mmHg Screening , 4. history multiple adverse drug reaction , 5. current/past history psychotic disorder , history outofbody feeling derealization , 6. active substance use disorder ( except nicotine caffeine ) within past six month past history ketamine/PCP ( phencyclidine ) abuse ( confirm collateral information doctor necessary ) , 7. requirement exclude medication may interact ketamine , 8. caffeine nicotine use within 1 hour psychophysiology testing , alcohol use within 1 day testing , 9. pregnancy , breastfeeding , unacceptable mean birth control ( female ) 10. clinically significant hearing impairment , 11. current serious suicidal homicidal risk , 12. concurrent participation research study involve medication treatment , 13. narrow angle glaucoma , 14. acute intermittent porphyria history , 15. history seizure past 6 month , regardless seizure type , 16. hyperthyroidism untreated hypothyroidism , 17. airway instability pulmonary disease hypercarbia , 18. current past cubital carpal tunnel syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>